Encompass Health (EHC) Common Equity (2009 - 2026)

Encompass Health has reported Common Equity for 18 years, with the latest figure at $3.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 14.82% year-over-year to $3.3 billion; the trailing twelve-month figure through Mar 2026 stood at $3.3 billion (up 14.82% YoY), and the FY2025 full-year result was $3.2 billion, up 15.21% from the prior year.
• Common Equity for Q1 2026 stood at $3.3 billion, up from $3.2 billion in the prior quarter.
• The five-year high for Common Equity was $3.3 billion in Q1 2026, with the low at $1.7 billion in Q3 2022.
• Historically, Common Equity has averaged $2.5 billion across 5 years, with a median of $2.4 billion in 2022.
• Annual changes were most pronounced in 2022 — Common Equity decreased 24.37% — and 2023, when it climbed 25.6%.
• Encompass Health's Common Equity stood at $1.8 billion in 2022, then grew by 23.48% to $2.3 billion in 2023, then climbed by 23.83% to $2.8 billion in 2024, then increased by 15.21% to $3.2 billion in 2025, then rose by 2.83% to $3.3 billion in 2026.
• The last three Common Equity figures came in at $3.3 billion (Q1 2026), $3.2 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.